Sign in

Transfusion Evidence Library

@transfusionlib.bsky.social
306 followers 530 following 446 posts

The #Transfusion Evidence Library provides access to evidence-based publications on all aspects of #TransfusionMedicine. It is updated monthly and free to use. #MedSky www.transfusionevidencelibrary.com

PostsRepliesMedia
Transfusion Evidence Library @transfusionlib.bsky.social · 49m
🔗See links to: 📄read the top articles featured in the #TransfusionEvidence Round-Up - #WorldPostpartumHaemorrhageDay 2026 www.transfusionevidencelibrary.com/alerts/latest 🎙️listen to the #TalkingTransfusion podcast: open.spotify.com/episode/1HEi... #MedSky @isbt.bsky.social
transfusionevidencelibrary.com
Transfusion Evidence Library
The Transfusion Evidence Library is a database of systematic reviews (since 1980) and randomised controlled trials (since 1950) relevant to transfusion medicine. It is fully searchable, updated monthl...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 50m
🔴 The #TransfusionEvidence Round-Up - #WorldPostpartumHaemorrhageDay 2026 is out! 🆕 See the links in the comments to read the top 10 articles and to listen to the #TalkingTransfusion podcast #MedSky @isbt.bsky.social
Image of an extract of the Transfusion Evidence Round-Up.Image of the banner about the Talking Transfusion Podcast - Episode 8: World Postpartum Haemorrhage Day 2026.
122
Transfusion Evidence Library @transfusionlib.bsky.social · 01/10/2026
Transfusion Evidence Library link to: Albumin for people with liver cirrhosis and bacterial infections by Simonetti et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Albumin for people with liver cirrhosis and bacterial infections
RATIONALE: People with liver cirrhosis are at an increased risk of bacterial infections, with a high rate of complications and mortality. Adding albumin to antibiotics may reduce their occurrence. OB...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 01/10/2026
📄From the #Transfusion Evidence Alert: Albumin for people with liver cirrhosis and bacterial infections by Simonetti et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Albumin for people with liver cirrhosis and bacterial infections by Simonetti et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Transfusion Evidence Library @transfusionlib.bsky.social · 01/10/2026
Transfusion Evidence Library link to: Larger versus smaller red blood cell volume per transfusion in hospitalized adults, children and preterm neonates by Roumeliotis et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Larger versus smaller red blood cell volume per transfusion in hospitalized adults, children and preterm neonates
RATIONALE: While substantial research has evaluated the safety of hemoglobin thresholds and storage length for red blood cell (RBC) transfusion, there is minimal literature on RBC transfusion volume p...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 01/10/2026
📄New from the #Transfusion Evidence Alert: Larger versus smaller red blood cell volume per transfusion in hospitalized adults, children and preterm neonates by Roumeliotis et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Larger versus smaller red blood cell volume per transfusion in hospitalized adults, children and preterm neonates by Roumeliotis et al.
Featured in the Transfusion Evidence Alert – September 2026
122
Transfusion Evidence Library @transfusionlib.bsky.social · 30/09/2026
Transfusion Evidence Library link to: Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial by Pène et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial
PURPOSE: Septic shock in cancer patients remains associated with a grim prognosis. With regard to the high prevalence of anemia, the optimal hemoglobin target to restore tissue oxygenation remains unc...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 30/09/2026
📄New from the #Transfusion Evidence Alert: Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial by Pène et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial by Pène et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Transfusion Evidence Library @transfusionlib.bsky.social · 30/09/2026
Transfusion Evidence Library link to: Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial by Myles et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial
OBJECTIVE: To evaluate the effects of intravenous iron on red cell transfusion and recovery after cardiac surgery. DESIGN: International, multicentre, double blind, placebo controlled randomised tria...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 30/09/2026
📄From the #Transfusion Evidence Alert: Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial by Myles et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial by Myles et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 30/09/2026
🔗 #StemCellEvidence link to: GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches by Kirshenboim et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches
BACKGROUND: The success of hematopoietic stem cell transplantation (HSCT) depends critically on human leukocyte antigen (HLA) matching between donor and recipient. While traditional matching focuses o...
021
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 30/09/2026
🟣 New from the #StemCellEvidence alert: 📑 GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches by Kirshenboim et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for:
GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches by Kirshenboim et al.
featured in the Stem Cell Evidence Alert - September 2026
132
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 29/09/2026
🟣 The #StemCellEvidence alert - September 2026, is out! 🔗 See the link in the comments for the top 10 articles #MedSky
Image showing an extract of the Stem Cell Evidence Alert - September 2026
121
Transfusion Evidence Library @transfusionlib.bsky.social · 29/09/2026
Transfusion Evidence Library link to: Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials by Łajczak et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials
Aneurysmal subarachnoid hemorrhage (aSAH) represents one of the acute neurological conditions associated with the highest morbidity and mortality, often complicated by early rebleeding in the hyperacu...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 29/09/2026
📄From the #Transfusion Evidence Alert: Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials by Łajczak et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials by Łajczak et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Transfusion Evidence Library @transfusionlib.bsky.social · 29/09/2026
Transfusion Evidence Library link to: All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia by Fu et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia
BACKGROUND: Eltrombopag is an effective second-line therapy for immune thrombocytopenia (ITP), but its long-term efficacy is limited. All-trans retinoic acid (ATRA) has immunomodulatory effects target...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 29/09/2026
📄New from the #Transfusion Evidence Alert: All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia by Fu et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia by Fu et al.
Featured in the Transfusion Evidence Alert – September 2026
133
Transfusion Evidence Library @transfusionlib.bsky.social · 28/09/2026
🔗 #Transfusion Evidence Library link to: Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia www.transfusionevidencelibrary.com/alerts/artic... #MedSky
transfusionevidencelibrary.com
Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia
Chronic liver disease (CLD)-related thrombocytopenia can limit the feasibility of invasive procedures. Recombinant human thrombopoietin (rhTPO) has demonstrated a favorable safety profile without hepa...
021
Transfusion Evidence Library @transfusionlib.bsky.social · 28/09/2026
🆕 From the #TransfusionEvidence Alert: 📑 Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia by Han et al. 🔗Link in the comments.
Image showing a PICO summary for:
Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia
by Han et al.
featured in the Transfusion Evidence Alert - September 2026
131
Transfusion Evidence Library @transfusionlib.bsky.social · 28/09/2026
🔗 #Transfusion Evidence Library link to: Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial www.transfusionevidencelibrary.com/alerts/artic... #MedSky
transfusionevidencelibrary.com
Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial
Eltrombopag combined with horse antithymocyte globulin and cyclosporine A (CSA) is the standard of care for patients with severe aplastic anemia who are not eligible for stem cell transplantation. No ...
031
Transfusion Evidence Library @transfusionlib.bsky.social · 28/09/2026
➡️New from the #TransfusionEvidence Alert: 📑Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial by Höchsmann et al. 🔗Link in the comments. #MedSky
Image showing a PICO summary for: Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial
by Höchsmann et al.
featured in the Transfusion Evidence Alert - September 2026
121
Transfusion Evidence Library @transfusionlib.bsky.social · 25/09/2026
Transfusion Evidence Library link to: Perioperative albumin versus other fluids to prevent cardiac surgery-associated kidney injury: a systematic review and meta-analysis of randomized trials by Darlison et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Perioperative albumin versus other fluids to prevent cardiac surgery-associated kidney injury: a systematic review and meta-analysis of randomized trials
OBJECTIVE: Cardiac surgery-associated acute kidney injury is a common and serious complication of cardiac surgery. Albumin solution is a commonly administered fluid in cardiac surgery patients; the ro...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 25/09/2026
📄From the #Transfusion Evidence Alert: Perioperative albumin versus other fluids to prevent cardiac surgery-associated kidney injury: a systematic review and meta-analysis of randomized trials by Darlison et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Perioperative albumin versus other fluids to prevent cardiac surgery-associated kidney injury: a systematic review and meta-analysis of randomized trials by Darlison et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Transfusion Evidence Library @transfusionlib.bsky.social · 25/09/2026
Transfusion Evidence Library link to: AI and Blood Banking: Predicting Transfusion Demand – A Systematic Review of Forecasting Approaches by Engelke et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
AI and Blood Banking: Predicting Transfusion Demand - A Systematic Review of Forecasting Approaches
INTRODUCTION: Accurate prediction of blood product demand is essential for maintaining adequate supply while minimizing wastage. Artificial intelligence (AI) and machine learning (ML) approaches have ...
010
Transfusion Evidence Library @transfusionlib.bsky.social · 25/09/2026
📄New from the #Transfusion Evidence Alert: AI and Blood Banking: Predicting Transfusion Demand – A Systematic Review of Forecasting Approaches by Engelke et al. 🔗 Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
AI and Blood Banking: Predicting Transfusion Demand – A Systematic Review of Forecasting Approaches by Engelke et al.
Featured in the Transfusion Evidence Alert – September 2026
144
Transfusion Evidence Library @transfusionlib.bsky.social · 24/09/2026
Transfusion Evidence Library link to: Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy by Bus et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
BACKGROUND: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a heterogeneous immune-mediated neuropathy that causes weakness and sensory deficits over the course of at least two mon...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 24/09/2026
📄From the #Transfusion Evidence Alert: Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy By Bus et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy by Bus et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Transfusion Evidence Library @transfusionlib.bsky.social · 24/09/2026
Transfusion Evidence Library link to: Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial by Spinella et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial
IMPORTANCE: Patients undergoing cardiac surgery with cardiopulmonary bypass often require platelet transfusions for bleeding. Platelets are routinely stored at room temperature (20-24 °C) for up to 5 ...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 24/09/2026
📆Article of the month from the #Transfusion Evidence Alert: Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial By Spinella et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial by Spinella et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Reposted by Transfusion Evidence Library
Systematic Review Initiative @sritransfusion.bsky.social · 24/09/2026
📆Today is #WorldCancerResearchDay. #StemCellTransplant is a valuable treatment option for some types of cancer, and our Stem Cell Evidence Library stores many articles on this topic. 🔗Link to the Stem Cell Evidence Library in replies
122
Transfusion Evidence Library @transfusionlib.bsky.social · 23/09/2026
🔗Link to the #TransfusionEvidence Alert: www.transfusionevidencelibrary.com/alerts/latest #MedSky
transfusionevidencelibrary.com
Transfusion Evidence Library
The Transfusion Evidence Library is a database of systematic reviews (since 1980) and randomised controlled trials (since 1950) relevant to transfusion medicine. It is fully searchable, updated monthl...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 23/09/2026
🆕 The #Transfusion Evidence Alert - September 2026 is out! 🩸See the latest top articles in #TransfusionMedicine ✅Each top article has a quick-format PICO summary 🔗Link in the comments #MedSky
Image showing an extract of the Transfusion Evidence Alert
132
Reposted by Transfusion Evidence Library
Systematic Review Initiative @sritransfusion.bsky.social · 17/09/2026
🟠Today we are celebrating #WorldPatientSafetyDay and also five years of the Transfusion Evidence Round-Up, which we produce in partnership with @isbt.bsky.social. 🔗Read more on the SRI website (link in replies)
Picture of the ISBT-SRI Transfusion Evidence Round-Up Team
143
Transfusion Evidence Library @transfusionlib.bsky.social · 13/09/2026
🔗Link to the #TransfusionEvidence Library: www.transfusionevidencelibrary.com #MedSky
transfusionevidencelibrary.com
Transfusion Evidence Library
The Transfusion Evidence Library is a database of systematic reviews (since 1980) and randomised controlled trials (since 1950) relevant to transfusion medicine. It is fully searchable, updated monthl...
001
Transfusion Evidence Library @transfusionlib.bsky.social · 13/09/2026
🌐This #WorldSepsisDay, we are highlighting the #sepsis filter in the #Transfusion Evidence Library. 🔍You can easily find the #sepsis filter, on the left hand side of the library, under Critical Care. 🔗See the link to #TransfusionEvidence Library in the comments below. #MedSky
Image showing the sepsis filter in the Transfusion Evidence Library
100
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026
🔗 #StemCellEvidence link to: CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial by Tang et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial
INTRODUCTION: Cytomegalovirus (CMV) reactivation is a major cause of mortality following haploidentical hematopoietic stem cell transplantation (haplo-HSCT). The application of conventional therapies ...
032
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026
🆕 From the #StemCellEvidence alert: 📑 CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial by Tang et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for: 
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial 
by Tang et al.
featured in the Stem Cell Evidence Alert - July/August 2026
132
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026
🔗 #StemCellEvidence link to: CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results by Silbert et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results
Multiantigen targeting chimeric antigen receptor (CAR) T cells have emerged as a strategy to mitigate antigen escape observed after single antigen targeting therapy. Our initial experience with a biva...
032
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026
🟣 New from the #StemCellEvidence alert: 📑 CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results by Silbert et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for:
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results 
by Silbert et al.
Link in the comments
featured in the Stem Cell Evidence Alert - July/August 2026
132
Transfusion Evidence Library @transfusionlib.bsky.social · 02/09/2026
Transfusion Evidence Library link to: Diagnostic accuracy of reticulocyte haemoglobin content in detecting iron deficiency without anaemia in blood donors: A systematic review and meta-analysis by Yanyiam et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Diagnostic accuracy of reticulocyte haemoglobin content in detecting iron deficiency without anaemia in blood donors: A systematic review and meta-analysis
BACKGROUND AND OBJECTIVES: Iron deficiency without anaemia (IDWA) is a significant concern among blood donors. Reticulocyte haemoglobin content (RHC) has been increasingly investigated as an alternative biomarker to evaluate iron status, but its diagnostic performance remains unclear. We aim to assess the diagnostic accuracy of RHC for detecting iron deficiency in non-anaemic blood donors. MATERIALS AND METHODS: PubMed, Embase, Scopus, Web of Science, Cochrane Library, ProQuest Dissertations & Theses, trial registries and reference lists were searched. Study quality was assessed using the Revised Tool for Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2), and the certainty of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. The pooled sensitivity, specificity, likelihood ratios (LRs) and summary receiver operating characteristic area under the curve (SROCAUC) were estimated. RESULTS: Thirteen studies involving 5853 donors were included. The pooled sensitivity, specificity, positive LR (LR+) and negative LR (LR-) of RHC to evaluate iron deficiency compared to tests using ferritin, soluble transferrin receptor or a combination of parameters were 0.70 (95% confidence interval [CI]: 0.60-0.79), 0.85 (95% CI: 0.74-0.92), 4.84 (95% CI: 2.59-9.04) and 0.35 (95% CI: 0.25-0.48), respectively; the SROCAUC was 0.82. The certainty of evidence was rated as very low to low. CONCLUSION: Evidence from this review is insufficient to support the widespread use of RHC as a standalone screening test for IDWA in blood donors. Further studies are needed to improve RHC-based screening strategies.
000
Transfusion Evidence Library @transfusionlib.bsky.social · 02/09/2026
📄New from the #Transfusion Evidence Alert: Diagnostic accuracy of reticulocyte haemoglobin content in detecting iron deficiency without anaemia in blood donors: A systematic review and meta-analysis By Yanyiam et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Diagnostic accuracy of reticulocyte haemoglobin content in detecting iron deficiency without anaemia in blood donors: A systematic review and meta-analysis by Yanyiam et al.
Featured in the Transfusion Evidence Alert – August 2026
122
Reposted by Transfusion Evidence Library
Systematic Review Initiative @sritransfusion.bsky.social · 01/09/2026
📆September is #BloodCancerAwarenessMonth. To honour this, episode 4 of our Talking Transfusion Podcast explores recent relevant findings, clinical challenges, and how transfusion supports those living with leukemia, lymphoma, myeloma, and related conditions. Links to the podcast here: bit.ly/45VghOf
bit.ly
Talking Transfusion Podcast
A collaborative podcast featuring the latest systematic reviews and trials
033
Transfusion Evidence Library @transfusionlib.bsky.social · 01/09/2026
Transfusion Evidence Library link to: Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial by Mora-Gonzalez et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial
OBJECTIVE: Excess body iron has been associated with hepatic insulin resistance and impaired glucose regulation. Whether mild iron reduction through blood donation benefits individuals with prediabete...
000
Transfusion Evidence Library @transfusionlib.bsky.social · 01/09/2026
📄New from the #Transfusion Evidence Alert: Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial By Mora-Gonzalez et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial by Mora-Gonzalez et al.
Featured in the Transfusion Evidence Alert – August 2026
122
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 01/09/2026
🔗 #StemCellEvidence link to: Reduced-Dose Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Matched Donor Allogeneic Stem Cell Transplantation: A #SystematicReview of Efficacy and Toxicity by Shafqat et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
Reduced-Dose Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Matched Donor Allogeneic Stem Cell Transplantation: A Systematic Review of Efficacy and Toxicity
The standard 100 mg/kg dose of post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis after matched allogeneic stem cell transplantation (ASCT) is associated with imp...
032
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 01/09/2026
🆕From the #StemCellEvidence alert: 📑Reduced-Dose Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Matched Donor Allogeneic Stem Cell Transplantation: A #SystematicReview of Efficacy and Toxicity by Shafqat et al. 🔗Link in the comments #MedSky
Image showing a PICO summary for: 
Reduced-Dose Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Matched Donor Allogeneic Stem Cell Transplantation: A Systematic Review of Efficacy and Toxicity 
by Shafqat et al.
featured in the Stem Cell Evidence Alert - July/August 2026
121
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 01/09/2026
🔗 #StemCellEvidence link to: Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes by Popat et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes
BACKGROUND: A myeloablative busulfan (Bu) and fludarabine (Flu) regimen that includes fractionating Bu and extending its delivery time results in low toxicity, permitting its use in stem cell transpla...
032
Reposted by Transfusion Evidence Library
Stem Cell Evidence @stemcellevidence.bsky.social · 01/09/2026
🟣 New from the #StemCellEvidence alert: 📑 Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes by Popat et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for:
Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes 
by Popat et al.
featured in the Stem Cell Evidence Alert - July/August 2026
132
Transfusion Evidence Library @transfusionlib.bsky.social · 31/08/2026
Transfusion Evidence Library link to: Adjuvant intravenous immunoglobulin in elderly sepsis: a randomized controlled study of mortality, organ function, and inflammation by Miao et al. www.transfusionevidencelibrary.com/alerts/artic...
transfusionevidencelibrary.com
https://www.transfusionevidencelibrary.com/alerts/articles/42422830
000
Transfusion Evidence Library @transfusionlib.bsky.social · 31/08/2026
📄 From the #Transfusion Evidence Alert: Adjuvant intravenous immunoglobulin in elderly sepsis: a randomized controlled study of mortality, organ function, and inflammation by Miao et al. 🔗 Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Adjuvant intravenous immunoglobulin in elderly sepsis: a randomized controlled study of mortality, organ function, and inflammation by Miao et al.
Featured in the Transfusion Evidence Alert – August 2026
100